Brain Advance Access published online on May 6, 2004
Brain, doi:10.1093/brain/awh162
© 2004 by Guarantors of Brain
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 National Stroke Research Institute, Melbourne, Australia; Department of Medicine, The University of Melbourne, Melbourne, Australia; Centre for Positron Emission Tomography, Austin Hospital, Melbourne, Australia
* To whom correspondence should be addressed. E-mail: godonnan{at}unimelb.edu.au.
In ischaemic stroke, expansion of the infarct core occurs at the expense of surrounding hypoxic, metabolically compromised tissue over a period of 24 h or more in a considerable proportion of patients. It is uncertain whether hypoxic tissue observed at later times after stroke onset retains the potential for survival or whether such survival has an impact on functional outcome. These factors may determine the effectiveness of therapeutic strategies aimed at salvaging this tissue. We tested the hypotheses that metabolically compromised hypoxic tissue observed within 48 h after onset of ischaemic stroke retains the potential for spontaneous survival and that the impact of such survival on functional outcome is time dependent. Consecutive patients presenting within 48 h of ischaemic stroke were studied with [18F]fluoromisonidazole, a ligand binding to hypoxic but viable tissue, and PET. Subjects were grouped into two time epochs, Key Words:
[18F]fluoromisonidazole; hypoxia; ischaemic stroke; penumbra; PET
Revised January 30, 2004
Accepted February 1, 2004
Article
Hypoxic tissue in ischaemic stroke: persistence and clinical consequences of spontaneous survival
2 National Stroke Research Institute, Melbourne, Australia; Department of Medicine, The University of Melbourne, Melbourne, Australia; Department of Neurology, Austin Hospital, Melbourne, Australia; Centre for Positron Emission Tomography, Austin Hospital, Melbourne, Australia
3 Department of Medicine, The University of Melbourne, Melbourne, Australia; Centre for Positron Emission Tomography, Austin Hospital, Melbourne, Australia
4 Centre for Positron Emission Tomography, Austin Hospital, Melbourne, Australia
5 Department of Neurology, Austin Hospital, Melbourne, Australia
Abstract 
12 and >12 h, based on the interval from stroke onset to the time of tracer injection, and had infarct volumes measured on CT/MRI at 7 days (n = 60). The total ischaemic volume (TIV) and the proportion of the TIV that spontaneously survived (surviving hypoxic volume ratio, SHVR) were defined from the co-registered CT/MRI images. These volumetric measures were correlated with neurological outcome assessed at day 7-10 by percentage change in the National Institutes of Health Stroke Scale (
NIHSS), and at 3 months by Barthel Index (BI) and modified Rankin Score (mRS). Of 66 patients investigated, hypoxic tissue occurred in 33 and outcome data was available in 27. Hypoxic tissue constituted >20% of the TIV in 60% of studies 12 h and 16% >12 h. The spontaneously surviving proportion of the TIV (median 6.9%) or hypoxic tissue (median 45.9%) was not significantly different in patient subgroups studied 12 or >12 h after stroke onset. Spontaneous survival of hypoxic tissue (surviving hypoxic volume ratio) was associated with improved neurological outcome in both time epochs: 12 h, NIHSS (r = 0.85, P < 0.01), day 90 BI (r = 0.86, P < 0.01) and day 90 mRS (r = -0.89, P < 0.01); >12 h, NIHSS (r = 0.59, P < 0.01) and day 90 mRS (r = -0.46, P < 0.05). The finding that similar proportions of hypoxic tissue survived spontaneously within each time epoch suggests that its fate is not predetermined. The favourable neurological outcome associated with spontaneous survival of hypoxic tissue, even 12-48 h after stroke onset, suggests that the volume of hypoxic tissue that progressed to infarction may represent a valuable target for therapeutic intervention.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Miteff, C. R. Levi, G. A. Bateman, N. Spratt, P. McElduff, and M. W. Parsons The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke Brain, August 1, 2009; 132(8): 2231 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Takasawa, R. R. Moustafa, and J.-C. Baron Applications of Nitroimidazole In Vivo Hypoxia Imaging in Ischemic Stroke Stroke, May 1, 2008; 39(5): 1629 - 1637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bardutzky, Q. Shen, N. Henninger, S. Schwab, T. Q. Duong, and M. Fisher Characterizing Tissue Fate After Transient Cerebral Ischemia of Varying Duration Using Quantitative Diffusion and Perfusion Imaging Stroke, April 1, 2007; 38(4): 1336 - 1344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-D. Heiss and A. G. Sorensen Advances in Imaging 2006 Stroke, February 1, 2007; 38(2): 238 - 240. [Full Text] [PDF]
|
|
|
|
|
|
N. J. Spratt, U. Ackerman, H. J. Tochon-Danguy, G. A. Donnan, and D. W. Howells Characterization of Fluoromisonidazole Binding in Stroke Stroke, July 1, 2006; 37(7): 1862 - 1867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Saver Time Is Brain--Quantified Stroke, January 1, 2006; 37(1): 263 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Baron and S. Warach Imaging Stroke, February 1, 2005; 36(2): 196 - 199. [Full Text] [PDF]
|
|